Role of GABA(A) receptors in the regulation of sleep: Initial sleep responses to peripherally administered modulators and agonists

Sleep

Volumn 22, Issue 1, 1999, Pages 33-42

  Lancel, Marike ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

GABA(A) receptor agonists agonistic modulators; Mammalia; Sleep state; Spectral analysis

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BENZODIAZEPINE DERIVATIVE; MUSCIMOL; ZOLPIDEM; ZOPICLONE; 4 AMINOBUTYRIC ACID RECEPTOR;

ARTICLE; DRUG EFFECT; DRUG RECEPTOR BINDING; HUMAN; PRIORITY JOURNAL; REM SLEEP; SPECTROSCOPY; ANIMAL; BRAIN; ELECTROENCEPHALOGRAPHY; RAT; REVIEW; TIME;

ANIMALS; BRAIN; ELECTROENCEPHALOGRAPHY; GABA AGONISTS; HUMANS; RATS; RECEPTORS, GABA; SLEEP, REM; TIME FACTORS;

EID: 0033068151     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/22.1.33     Document Type: Article

References (128)

1. Fahn S, Côté LJ. Regional distribution of γ-aminobutyric acid (GABA) in brain of the Rhesus monkey. J Neurochem 1968; 15: 209-13.
2. Perry TL, Berry K, Hansen S, Diamond S, Mok C. Regional distribution of amino acids in human brain obtained at autopsy. J Neurochem 1971; 18: 513-9.
3. Bloom FE, Iversen LL. Localizing 3H-GABA in nerve terminals of rat cerebral cortex by electron microscopic autoradiography. Nature 1971; 229: 628-30.
4. Roberts E, Frankel S. γ-aminobutyric acid in brain: its formation from glutamic acid. J Biol Chem 1974; 187: 55-63.
5. A receptor subtypes. Pharmacol Rev 1995; 47: 181-234.
6. B receptors. The GABA receptors. In: Enna SJ, Bowery NG, eds. Totowa, NJ: The Humana Press Inc., 1997: 157-207.
7. C receptors. In: Enna SJ, Bowery NG, eds. The GABA receptors. Totowa, NJ: The Humana Press Inc., 1997:297-323.
8. A receptor agonists, partial agonists, and antagonists. In: Enna SJ, Bowery NG, eds. The GABA receptors. Totowa, NJ: The Humana Press Inc., 1997:37-81.
9. B receptors in mammalian brain: potential targets for drug development. Drug Dev Res 1990;21:161-7.
10. A receptor channels. Annu Rev Neurosci 1994;17:569-602.
11. A receptors. Biochem J 1995;310:1-9.
12. A receptor subunit for benzodiazepine pharmacology. Nature 1989;338:582-5.
13. A receptors on channel function. Neuron 1990;5:703-11.
14. A/benzodiazepine receptor heterogeneity: neurophysiological implications. Neuropharmacology 1995;34:245-54.
15. A receptor pharmacology. Pharmacol Ther 1996;69:173-98.
16. Study RE, Barker JL. Diazepam and (-)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of γ-aminobutyric acid responses in cultured central neurons. Proc Natl Acad Sci USA 1981;78:7180-4.
17. A receptor channel of mouse spinal cord neurones in culture. J Physiol 1989;417:483-500.
18. Macdonald RL, Barker JL. Anticonvulsant and anesthetic barbiturates: different postsynaptic actions in cultured mammalian neurons. Neurology 1979;29:432-47.
19. B receptor subtypes. Trends Neurosci 1988;11:112-6.
20. Scherschlicht R, Marias J, Schneeberger J, Steiner M. Model insomnia in animals. In: Koella WP, eds. Sleep 1980. 5th Europ. Congr. Sleep Research., Amsterdam 1980. Basel: Karger, 1981:147-55.
21. Hinman DJ, Okamoto M. Sleep patterns in cats during chronic low-dose barbiturate treatment and withdrawal. Sleep 1984;7:69-76.
22. Hara T, Masuda K, Miyake H. Effects of psychotropic drugs on the PGO waves occurring in REM sleep and on the reserpine-induced PGO waves. In: Weitzman ED, eds. Advances in Sleep Research, Vol. 2. New York: Spectrum Publications Inc., 1975:131-54.
23. Gottesmann C, Gandolfo G, Arnaud C, Gauthier P. Influence of three generations of hypnotics on the intermediate stage and paradoxical sleep in the rat: a synopsis. Eur J Neurosci 1998;2:409-14.
24. Neckelmann D, Ursin R. Sleep stages and EEG power spectrum in relation to acoustical stimulus arousal thresholds in the rat. Sleep 1993;16:467-77.
25. Gottesmann C, Gandolfo G, Zernicki B. Intermediate stage of sleep in the cat. J Physiol (Paris) 1984;79:365-72.
26. Schallek W, Schlosser W. Neuropharmacology of sedatives and anxiolytics. Mod Probl Pharmacopsych 1979;14:157-73.
27. Steriade M, McCormick DA. Thalamocortical oscillations in the sleeping and aroused barin. Science 1993;262:679-85.
28. Lester BK, Guerrero-Figueroa R. Effects of some drugs on electroencephalographic fast activity and dream time. Psychophysiology 1966;2:224-36.
29. Rosadini G, Masturzo P, Rodriguez G, Murialdo G, Montano V, Bonura ML, Polleri A. Effects of a single oral dose of phenobarbital on prolactine, growth hormone and luteinizing hormone in normal women. Acta Endocrinologica 1983;103:309-14.
30. Baekland F. Pentobarbital and dextroamphetamine sulfate: effects on the sleep cycle in man. Psychopharmacologia 1967;11:388-96.
31. Hartmann E. The effect of four drugs on sleep patterns in man. Psychopharmacologia 1968;12:346-53.
32. Haider I, Oswald I. Effects of amylobarbitone and nitrazepam on the electrodermogram and other features of sleep. Brit J Psychiat 1971;118:519-22.
33. Oswald I, Berger RJ, Jaramillo RA, Keddie KMG, Olley PC, Plunkett GB. Melancholia and barbiturates: a controlled EEG, body and eye movement study of sleep. Brit J Psychiat 1963;109:66-78.
34. Lehmann HE, Ban TA. The effect of hypnotics on rapid eye movement (REM). Int J Clin Pharmacol 1968;1:424-7.
35. Lester BK, Coulter JD, Cowden LC, Williams HL. Secobarbital and nocturnal physiological patterns. Psychopharmcologia 1968;13:275-86.
36. Allnutt MF, O'Connor PJ. Comparison of the encephalographic, behavioral and subjective correlates of natural and drug-induced sleep at atypical hours. Aerosp Med 1971;42:1006-10.
37. Lader M. Rebound insomnia and newer hypnotics. Psychopharmacology 1992;108:248-55.
38. Walsh JK, Engelhardt CL. Trends in the pharmacologic treatment of insomnia. J Clin Psychiat 1992;53 Suppl:10-7.
39. Barker JL, Harrison NL, Mariani AP. IV. Benzodiazepine pharmacology of cultured mammalian CNS neurons. Life Sci 1986;39:1959-68.
40. Monti JM, Altier H, D'Angelo L. Diazepam, GABA agonists and antagonists and the sleep-wakefulness cycle. In: Passouant P, Oswald I, eds. Pharmacology of the states of alertness. Oxford: Pergamon Press, 1979:65-71.
41. Meltzer LT, Serpa KA. Assessment of hypnotic effects in the rat: influence of the sleep-awake cycle. Drug Dev Res 1988;14:151-9.
42. Mendelson WB, Martin JV. Effects of muscimol and flurazepam on the sleep EEG in the rat. Life Sci 1990;47:PL99-101.
43. Edgar DM, Seidel WF, Dement WC. Triazolam-induced sleep in the rat: influence of prior sleep, circadian time, and light/dark cycles. Psychopharmacology 1991;105:374-80.
44. Mendelson WB, Monti D. Do benzodiazepines induce sleep by a GABAergic mechanism? Life Sci 1993;53:PL81-7.
45. Lancel M, Crönlein TAM, Müller-Preuß P, Holsboer F. Pregnenolone enhances EEG delta activity during non-rapid eye movement sleep in the rat, in contrast to midazolam. Brain Res 1994;646:85-94.
46. Depoortere H, Françon D, van Luijtelaar ELJM, Drinkenburg WHIM, Coenen AML. Differential effects of midazolam and zolpidem on sleep-wake states and epileptic activity in WAG/Rij rats. Pharmacol Biochem Behav 1995;51:571-6.
47. A receptors in sleep regulation: differential effects of muscimol and midazolam on sleep in rats. Neuropsychopharmacology 1996;15:63-74.
48. Edgar DM, Seidel WF, Gee KW, Lan NC, Field G, Xia H, Hawkinson JE, Wieland S, Carter RB, Wood PL. CCD-3693: an orally bioavailable analog of the endogenous neuroactive steroid, pregnanolone, demonstrates potent sedative hypnotic actions in the rat. J Pharmacol Exp Ther 1997;282;420-9.
49. Lanoir J, Killam EK. Alteration in the sleep-wakefulness patterns by benzodiazepines in the cat. Electroenceph Clin Neurophysiol 1968;25:530-42.
50. Pole P, Haefely W. Effects of flunitrazepam on the sleep of cats. In: Levin P, Koella WP. eds. Sleep 1974. 2nd Europ. Congr Sleep Res, Rome 1974. Basel: Karger, 1975:303-5.
51. Depoortere H, Decobert M, Granger P, Riou-Merle F. Hypnotics: clinical value of pharmaco-EEG methods. Neuropsychobiology 1986;16:157-62.
52. Hashimoto T, Hamada C, Wada T, Fukuda N. Comparative study on the behavioral and EEG changes induced by diazepam, buspirone and a novel anxioselective anxiolytic, DN-2327, in the cat. Neuropsychobiology 1992;26:89-99.
53. Gaillard JM, Schulz P, Tissot R. Effects of three benzodiazepines (nitrazepam, flunitrazepam and bromazepam) on sleep of normal subjects, studied with an automatic sleep scoring system. Pharmakopsychiat 1973;6:207-17.
54. Monti JM, Altier H. Flunitrazepam (Ro 5-4200) and sleep cycle in normal subjects. Psychopharmacologia (Berl) 1973;32:343-9.
55. Cerone G, Cirignotta F, Coccagna G, Ferro Milone F, Lion P, Lorizio A, Lugaresi E, Mantovani M, Muratorio A, Murri L, Mutani R, Roccio A. All-night polygraphic recordings on the hypnotic effects of a new benzodiazepine: flunitrazepam (Ro 5-4200, rohypnol®). Europ Neurol 1974;11:172-9.
56. Gaillard JM, Blois R. Differential effects of flunitrazepam on human sleep in combination with flumazenil. Sleep 1989;12:120-32.
57. Borbély AA, Mattmann P, Loepfe M, Strauch I, Lehmann D. Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum Neurobiol 1985;4:189-94.
58. Lechner H. Effect of mogadon on night-time sleep. Prog Brain Res 1965;18:225-6.
59. Oswald I, Priest RG Five weeks to escape the sleeping-pill habit. Brit Med J 1965;2:1093-5.
60. Gastaut H, Lob H, Papy JJ. Action of mogadon on the stages of REM sleep. Electroenceph Clin Neurophysiol 1967;23:288.
61. Adam K, Adamson L, Brezinová V, Hunter WM, Oswald I. Nitrazepam: lastingly effective but trouble on withdrawal. Brit Med J 1976;1:1558-60.
62. Ogura C, Nakazawa K, Majima K, Ueda H, Umezawa Y, Wardell WM. Residual effects of hypnotics: triazolam, flurazepam, and nitrazepam. Psychopharmacology 1980;68:61-5.
63. Kales A, Kales JD, Scharf MB, Tan TL. Hypnotics and altered sleep-dream patterns. II. All-night EEG studies of chloral hydrate, flurazepam, and methaqualone. Arch Gen Psychiat 1970;23:219-25.
64. Johns MW, Masterton JP. Effect of flurazepam on sleep in the laboratory. Pharmacology 1974;11:358-64.
65. Feinberg I, Fein G, Walker JM, Price LJ, Floyd TC, March JD. Flurazepam effects on sleep EEG Arch Gen Psychiat 1979;36:95-102.
66. Karacan I, Orr W, Roth T, Kramer M, Thornby J, Bingham S, Kay D. Dose-related effects of flurazepam on human sleep-waking patterns. Psychopharmacology 1981;73:332-9.
67. Ferrillo F, Balestra V, Carta F, Nuvoli G, Pintus C, Rosadini G. Comparison between the central effects of camazepam and temazepam. Computerized analysis of sleep recordings. Neuropsychobiology 1984;11:72-6.
68. 2 antagonist, and temazepam on human sleep stages and EEG power spectra. Eur J Pharmacol 1989;171:207-18.
69. Itil TM, Saletu B, Marasa J. Determination of drug-induced changes in sleep quality based on digital computer "sleep prints". Pharmakopsychiat 1974;240:265-80.
70. Roth T, Kramer M, Schwartz JL. Triazolam: a sleep laboratory study of a new benzodiazepine hypnotic. Curr Ther Res 1974;16:117-23.
71. Nicholson AN, Stone BM. Activity of the hypnotics, flunitrazepam and triazolam, in man. Br J Clin Pharmacol 1980;9:187-94.
72. Trachsel L, Dijk DJ, Brunner DP, Klene C, Borbély AA. Effect of zopiclone and midazolam on sleep and EEG spectra in a phase-advanced sleep schedule. Neuropsychopharmacology 1990;3:11-8.
73. Achermann P, Borbély AA. Dynamics of EEG slow wave activity during physiological sleep and after administration of benzodiazepine hypnotics. Hum Neurobiol 1987;6:203-10.
74. Borbély AA, Achermann P. Ultradian dynamics of sleep after a single dose of benzodiazepine hypnotics. Eur J Pharmacol 1991;195:11-8.
75. Aeschbach D, Dijk DJ, Trachsel L, Brunner D, Borbély AA. Dynamics of slow-wave activity and spindle frequency activity in the human sleep EEG: effect of midazolam and zopiclone. Neuropsychopharmacology 1994;11:237-44.
76. Feinberg I, Fein G, Walker JM, Price LJ, Floyd TC, March JD. Flurazepam effects on slow-wave sleep: stage 4 suppressed but number of delta waves constant. Science 1977;198;847-8.
77. Johnson LC, Seales DM, Naitoh P, Church MW, Sinclair M. The effects of flurazepam hydrochloride on brain electrical activity during sleep. Electroenceph Clin Neurophysiol 1979;47:309-21.
78. Johnson LC, Spinweber CL. Effect of a short-acting benzodiazepine on brain electrical activity during sleep. Electroenceph Clin Neurophysiol 1981;52:89-97.
79. Johnson LC, Hanson K, Bickford RG. Effect of flurazepam on sleep spindles and K-komplexes. Electroenceph Clin Neurophysiol 1976;40:67-77.
80. Wadworth AN, McTavish D. Zopiclone. A review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs & Aging 1993;3:441-59.
81. Monti JM, Attali P, Monti D, Zipfel A, de la Giclais B, Morselli PL. Zolpidem and rebound insomnia - a double-blind, controlled polysomnographic study in chronic insomniac patients. Pharmacopsychiatry 1994;27:166-75.
82. Lader M. Zopiclone: Is there any dependence and abuse potential? J Neural 1997;244 (Suppl 1):S18-22.
83. Noble S, Langtry HD, Lamb HM. Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia. Drugs 1998;55:279-302.
84. Depoortere H, Zivkovic B, Lloyd KG, Sanger DJ, Perrault G, Langer SZ, Bartholini G. Zolpidem, a novel nonbenzodiazepine hypnotic. I. neuropharmacological and behavioral effects. J Pharmacol Exp Ther 1986;237:649-58.
85. Nicholson AN, Pascoe PA. Hypnotic activity of zolpidem: nighttime and daytime studies in young and middle-aged adults. In: Sauvanet JP, Langer SZ, Morselli PL, eds. Imidazopyridines in Sleep Disorders. New York; Raven Press, 1988:231-40.
86. Lund R, Rüther E, Wober W, Hippius H. Effects of zolpidem (10 and 20 mg), lormetazepam, triazolam and placebo on night sleep and residual effects during the day. In: Sauvanet JP, Langer SZ, Morselli PL, eds. Imidazopyridines in Sleep Disorders. New York; Raven Press, 1988:193-203.
87. Merlotti L, Roehrs T, Koshorek G, Zorick F, Lamphere J, Roth T. The dose effects of zolpidem on the sleep of healthy normals. J Clin Psychopharmacol 1989;9:9-14.
88. Brunner DP, Dijk DJ, Münch M, Borbély AA. Effect of zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology 1991;104:1-5.
89. Scharf MB, Mayleben DW, Kaffeman M, Krall R, Ochs R. Dose response effects of zolpidem in normal geriatric subjects. J Clin Psychiatry 1991;52:77-83.
90. Stutzmann JM, Piot O, Reibaud M, Doble A, Blanchard JC. Pharmacological properties and mechanism of action of the cyclopyrrones. L'Encéphale 1992:XVIII 393-400.
91. Gauthier P, Arnaud C, Stutzmann JM, Gottesmann C. Influence of zopiclone, a new generation hypnotic, on the intermediate stage and paradoxical sleep in the rat. Psychopharmacology 1997;130:139-43.
92. Julou L, Bardone MC, Blanchard JC, Garret C, Stutzmann JM. Pharmacological studies on zopiclone. Pharmacology 1983;27 (Suppl 2):46-58.
93. Nicholson AN, Stone BM. Efficacy of zopiclone in middle age. Sleep 1987;10 (Suppl 1);35-9.
94. Godtlibsen OB, Dreyfus JF. Effect of 7.5 mg zopiclone (27.267 RP) on sleep pattern in normal subjects. Waking Sleeping 1980;4:319-25.
95. Hayashida N, Nakazawa Y, Sakamoto T, Uchimura N, Kuroda K, Hashizume Y, Tsuchiya S, Tsutsumi Y. Effects of zopiclone on slow wave sleep and spontaneous K-complexes for normal healthy young adults. Jpn J Psychiatr Neurol 1993;47:893-9.
96. Mann K, Bauer H, Hiemke C, Röschke J, Wetzel H, Benkert O. Acute, subchronic and discontinuation effects of zopiclone on sleep EEG and nocturnal melatonin secretion. Europ Neuropsychopharmacol 1996;6:163-8.
97. Yamadera H, Kato M, Tsukahara Y, Kajimura N, Okuma T. Relationship between the effects of a hypnotic drug, zopiclone, on polysomnography and on daytime EEGs. Neuropsychobiology 1997;35:152-5.
98. Billiard M, Besset A, de Lustrac C, Brissaud L. Dose-response effects of zopiclone on night sleep and on nighttime and daytime functioning. Sleep 1987;10 (Suppl 1):27-34.
99. Kanno O, Watanabe H, Kazamatsuri H. Effects of zopiclone, flunitrazepam, triazolam and levomepromazine on the transient change in sleep-wake schedule: polygraphic study, and the evaluation of sleep and daytime condition. Prog Neuro-Psychopharmacol Biol Psychiat 1993;17:229-39.
100. Kim Y, Zhuang H, Tsutsumi M, Okabe A, Kurachi M, Kamikawa Y. Comparison of the effect of zopiclone and brotizolam on sleep EEG by quantitative evaluation in healthy young women. Sleep 1993;16:655-61.
101. Wright NA, Belyavin A, Borland RG, Nicholson AN. Modulation of delta activity by hypnotics in middle-aged subjects: studies with a benzodiazepine (flurazepam) and a cyclopyrrolone (zopiclone). Sleep 1986;9:348-52.
102. Jobert M, Poiseau E, Jähnig P, Schulz H, Kubicki S. Pattern recognition by matched filtering: an analysis of sleep spindle and K-complex density under the influence of lormetazepam and zopiclone. Neuropsychobiology 1992;26:100-7.
103. Deutsch SI, Mastropaolo J, Hitri A. GABA-active steroids: endogenous modulators of GABA-gated chloride ion conductance. Clin Neuropharmacol 1992;15:352-64.
104. A Receptors and Anxiety: From Neurobiology to Treatment. New York: Raven Press, 1995:57-74.
105. Rupprecht R. The neuropsychopharmacological potential of neuroactive steroids. J Psychiat Res 1997;31:297-314.
106. A receptor by depressant barbiturates and pregnane steroids. Br J Pharmacol 1988;94:1257-69.
107. A receptor by progesterone metabolites. Proc R Soc Lond 1987;231:359-69.
108. Harrison NL, Majewska MD, Harrington JW, Barker JL. Structure-activity relationships for steroid interaction with the g-aminobutyric acid-A receptor complex. J Pharmacol Exp Ther 1987;214:346-53.
109. Selye H. Correlations between the chemical structure and the pharmacological actions of the steroids. Endocrinology 1942;3:437-53.
110. A receptor modulators. Am J Physiol 1996;271:E763-72.
111. Friess E, Tagaya H, Trachsel L, Holsboer F, Rupprecht R. Progesterone-induced changes in sleep in male subjects. Am J Physiol 1997;272:E885-91.
112. Schulz H, Jobert M, Gee KW, Ashbrook DW. Soporific effect of the neurosteroid pregnanolone in relation to the substance's plasma level: a pilot study. Neuropsychobiology 1996;34:106-12.
113. Mendelson WB, Martin JV, Perus M, Wagner R, Majewska MD, Paul SM. Sleep induction by an adrenal steroid in the rat. Psychopharmacology 1987;93:226-9.
114. Lancel M, Faulhaber J, Schiffelholz T, Romeo E, Di Michele F, Holsboer F, Rupprecht R. Allopregnanolone affects sleep in a benzodiazepine-like fashion. J Pharmacol ExpTher 1997;282:1213-8.
115. Gillin JC, Jacobs LS, Snyder F, Henkin RI. Effects of decreased adrenal corticosteroids: changes in sleep in normal subjects and patients with adrenal cortical insufficiency. Electroenceph Clin Neurophysiol 1974;36:283-9.
116. Steiger A, Rupprecht R, Spengler D, Guldner J, Hemmeter U, Rothe B, Damm K, Holsboer F. Functional properties of deoxycorticosterone and spironolactone: molecular characterization and effects on sleep-endocrine activity. J Psychiat Res 1993;27:275-84.
117. Lancel M, Faulhaber J, Schiffelholz T, Mathias S, Deisz RA. Muscimol and midazolam do not potentiate each other's effects on sleep EEG in the rat. J Neurophysiol 1997;77:1624-9.
118. A agonist THIP (gaboxadol) increases non-REM sleep and enhances delta activity in the rat. NeuroReport 1996;7:2241-5.
119. A agonist THIP increases non-REM sleep and enhances non-REM sleep-specific delta activity in the rat during the dark period. Sleep 1997; 20:1099-104.
120. A agonist THIP produces slow wave sleep and reduces spindling activity in NREM sleep in humans. Psychopharmacology 1997;130:285-91.
121. Borbély AA, Åkerstedt T, Benoit O, Holsboer F, Oswald I. Hypnotics and sleep physiology: a consensus report. Eur Arch Psychiatry Clin Neurosci 1991;241:13-21.
122. Vergnes M, Marescaux C, Micheletti G, Depaulis A, Rumbach L, Warter JM. Enhancement of spike and wave discharges by GABAmimetic drugs in rats with spontaneous petit mal-like epilepsy. Neurosci Lett 1984;44:91-4.
123. Marescaux C, Micheletti G, Vergnes M, Rumbach L, Warter JM. Diazepam antagonizes GABAmimetics in rats with spontaneous petit mal-like epilepsy. Eur J Pharmacol 1985;113:19-24.
124. Garcha HS, Rose IC, Stolerman IP. Midazolam cue in rats: generalization tests with anxiolytic and other drugs. Psychopharmacology 1985;87:233-7.
125. Ator NA, Grant KA, Purdy RH, Paul SM, Griffiths RR. Drug discrimination analysis of endogenous neuroactive steroids in rats. Eur J Pharmacol 1993;241:237-43.
126. Rauch RJ, Stolerman IP. Midazolam cue in rats: effects of drugs acting on GABA and 5-hydroxytryptamine systems, anticonvulsants and sedatives. J Psychopharmacol 1987;2:71-80.
127. Iversen LL, Kelly JS. Uptake and metabolism of γ-aminobutyric acid by neurones and glial cells. Biochem Pharmacol 1975;24:933-8.
128. Lancel M, Faulhaber J, Deisz R. Effect of the GABA uptake inhibitor tiagabine on sleep and EEG power spectra in the rat. Br J Pharmacol 1998;123:1471-7.